azacitidine,quizartinib,venetoclax,cytarabine
roche,daiichi sankyo,abbvie
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'cytarabine', 'venetoclax']
congress | #eha2023 juan miguel bergua burgues, hospital san pedro de alc ntara, presents updated results from a phase i/ii trial assessing the safety &amp; efficacy of triplet combinations of azacitidine or low-dose cytarabine with venetoclax &amp; quizartinib in nd unfit pts with aml. 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm